Oregano and Drug Interactions Study
This study is looking at how the dietary supplement oregano (oil of oregano, 180 mg softgel) might affect how your body handles certain medications. Researchers will give participants a "drug cocktail" containing common medicines like caffeine, dextromethorphan, losartan, midazolam, and omeprazole. The main goal is to see how oregano changes the levels of midazolam in your blood over 24 hours. This study is for healthy adults aged 18 to 64 who are not taking other medications or supplements that could interfere. The study is currently recruiting 16 participants.
- Study design
- This is an interventional study with 16 planned participants, but the phase is not specified. It is not stated if it is randomized or blinded.
- What's involved
- You would need to abstain from certain dietary/herbal supplements, citrus juices, cannabis, hemp, and THC/CBD products for several weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Midazolam levels will be measured for 24 hours after administration.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Midazolam Area under the plasma concentration vs. time curve (AUC) ratio0-24 hours
Ratio of the area under the plasma concentration vs. time curve of midazolam in the presence to absence of oregano.